anonymous
Guest
anonymous
Guest
Regeneron owns the molecule.Why would Regeneron get Praluent when they haven’t had any budget since CVOT launch? Wouldn’t it make sense for us to get it 100% and sell with Multaq. I think we are good for a few more years!